Amy M.B. McCorry - Concepedia

Author

Amy M.B. McCorry

Queen's University Belfast ORCID

Also Known As

Amy M B McCorry, Amy M. B. McCorry, Amy M. McCorry, Amy M.B. McCorry, Amy MB McCorry, Amy McCorry

Publications

620

Citations

H-Index

Concepts

All Affiliations

Queen's University Belfast University of Oxford University of Glasgow Cancer Research UK Scotland Institute Belfast Health and Social Care Trust

About

Amy M.B. McCorry is an author at Queen's University Belfast specializing in cancer research, medicine, and tumor biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Health Sciences	1	1	67
2	Medicine	1	1	67
3	Biostatistics	1	1	67
4	Pathology	1	1	67
5	Cancer Cell Biology	1	1	67

Amy M.B. McCorry

Publications

603

Citations

H-Index

Page 1

	Year	Citations
Development and Validation of a 28-gene Hypoxia-related Prognostic Signature for Localized Prostate Cancer Lingjian Yang, Darren L. Roberts, Mandeep Takhar, EBioMedicine	2018	154
Dynamic and adaptive cancer stem cell population admixture in colorectal neoplasia Ester Gil Vazquez, Nadia Nasreddin, Gabriel N. Valbuena, Cell stem cell	2022	107
Cancer-cell intrinsic gene expression signatures overcome intratumoural heterogeneity bias in colorectal cancer patient classification Philip D. Dunne, Matthew Alderdice, Paul G. O’Reilly, Nature Communications	2017	95
Validation of the systematic scoring of immunohistochemically stained tumour tissue microarrays using <i>QuPath</i> digital image analysis Maurice B. Loughrey, Peter Bankhead, Helen G. Coleman, Histopathology	2018	75
Prospective patient stratification into robust cancer‐cell intrinsic subtypes from colorectal cancer biopsies Matthew Alderdice, Susan D. Richman, Simon Gollins, The Journal of Pathology Colorectal Cancer BiopsiesPathologyTumor BiologyBiopsy TissueOncology	2018	67
Epithelial‐to‐mesenchymal transition signature assessment in colorectal cancer quantifies tumour stromal content rather than true transition Amy M.B. McCorry, Maurice B. Loughrey, Daniel B. Longley, The Journal of Pathology	2018	38
Fibroblast-derived Gremlin1 localises to epithelial cells at the base of the intestinal crypt Louise Dutton, Owen Hoare, Amy M.B. McCorry, Oncotarget	2019	25
Activation of innate-adaptive immune machinery by poly(I:C) exposes a therapeutic vulnerability to prevent relapse in stroma-rich colon cancer Shania M. Corry, Amy M.B. McCorry, Tamsin R.M. Lannagan, Gut	2022	19
Epithelial TGFβ engages growth-factor signalling to circumvent apoptosis and drive intestinal tumourigenesis with aggressive features Dustin J. Flanagan, Raheleh Amirkhah, David F. Vincent, Nature Communications	2022	12
<i>Bcl-xL</i> as a poor prognostic biomarker and predictor of response to adjuvant chemotherapy specifically in <i>BRAF</i> -mutant stage II and III colon cancer Philip D. Dunne, Helen G. Coleman, Peter Bankhead, Oncotarget	2018	11

Page 1